Protective Effects of DHA-PC against Vancomycin-Induced Nephrotoxicity through the Inhibition of Oxidative Stress and Apoptosis in BALB/c Mice
- 2 January 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 66 (2) , 475-484
Abstract
The clinical use of glycopeptide antibiotic vancomycin is usually accompanied by nephrotoxicity, limiting its application and therapeutic efficiency. The aim of this study was to investigate the protection of DHA-enriched phosphatidylcholine (DHA-PC) against nephrotoxicity using a model of vancomycin-induced male BALB/c mice with renal injury by measuring death curves, histological changes and renal function indexes. The addition of DHA in DHA and DHA-PC groups were 300 mg/kg per day on the basis of human intake level in our study. Results indicated that DHA-PC could dramatically extend the survival time of mice, while traditional DHA and PC had no significant effects. Moreover, oral administration of DHA-PC exhibited better effects on reducing vancomycin-induced increases of blood urea nitrogen, creatinine, Cystatin C and kidney injury molecule-1 levels than traditional DHA and PC. DHA-PC significantly delayed the development of vancomycin-induced renal injury, including tubular necrosis, hyaline casts, and tubular degeneration. A further mechanistic study revealed that the protective effect of DHA-PC on vancomycin-mediated toxicity might be attributed to its ability to inhibit oxidative stress and inactivate mitogen-activated protein kinase (MAPK) signaling pathways, which was associated with upregulation of Bcl-2 and downregulation of Caspase-9, Caspase-3, Cytochrome-c, p38 and JNK. These findings suggest that DHA-PC may be acted as the dietary supplements or functional foods against vancomycin-induced nephrotoxicity.Keywords
Funding Information
- Ministry of Education of the People's Republic of China (201762028)
- Shandong Province (U1606403)
- National Natural Science Foundation of China (31330060, 31371757, U1606403)
This publication has 49 references indexed in Scilit:
- Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signalingToxicology and Applied Pharmacology, 2017
- In vivo protective effect of phosphatidylcholine on carbon tetrachloride induced nephrotoxicityExperimental and Toxicologic Pathology, 2016
- Review of vancomycin-induced renal toxicity: an updateTherapeutic Advances in Endocrinology and Metabolism, 2016
- Vancomycin-Associated Nephrotoxicity: The Obesity FactorSurgical Infections, 2015
- Vancomycin‐Associated Renal Dysfunction: Where Are We Now?Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014
- Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: Involvement of mitochondria-regulated apoptosisToxicology, 2014
- Protective role of phosphatidylcholine against cisplatin-induced renal toxicity and oxidative stress in ratsFood and Chemical Toxicology, 2013
- Review of Continuous-Infusion VancomycinAnnals of Pharmacotherapy, 2013
- Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature reviewEuropean Journal of Clinical Pharmacology, 2012
- Protective Effects of Caffeic Acid Phenethyl Ester, Vitamin C, Vitamin E and N‐Acetylcysteine on Vancomycin‐Induced Nephrotoxicity in RatsBasic & Clinical Pharmacology & Toxicology, 2007